Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent.
Küchle
C C
CC
Department of Internal Medicine, Klinikum Innenstadt, University of Munich, Germany.
Thoenes
G H
GH
Langer
K H
KH
Schorlemmer
H U
HU
Bartlett
R R
RR
Schleyerbach
R
R
D000818:Animals; D004305:Dose-Response Relationship, Drug; D006084:Graft Rejection / Q000187:drug effects*; D006085:Graft Survival / Q000187:drug effects; D007166:Immunosuppressive Agents; D007555:Isoxazoles / Q000494:pharmacology*; D007668:Kidney / Q000473:pathology / Q000502:physiology; D016030:Kidney Transplantation / Q000276:immunology*; D000077339:Leflunomide; D051381:Rats; D011919:Rats, Inbred Strains; D016038:Skin Transplantation / Q000276:immunology*; D013997:Time Factors
D007166:Immunosuppressive Agents; D007555:Isoxazoles; D000077339:Leflunomide